Table 2:
Quantile and Effect | Std. Error | Pr(>|t|) | Quantile andEffect | Std. Error | Pr(>|t|) | ||
---|---|---|---|---|---|---|---|
0.25 | 0.75 | ||||||
12–10 Months1 | −2.33 | 0.68 | *** | 12–10 Months | −1.65 | 0.49 | *** |
10–8 Months | 1.33 | 0.33 | *** | 10–8 Months | 0.33 | 0.26 | |
8–6 Months | −0.67 | 0.32 | * | 8–6 Months | −1.01 | 0.35 | *** |
6–4 Months | −1.00 | 0.45 | * | 6–4 Months | −0.15 | 0.20 | |
4–2 Months | −2.26 | 0.54 | *** | 4–2 Months | −0.36 | 0.22 | |
2–0 Months | −11.24 | 0.66 | *** | 2–0 Months | −1.61 | 0.35 | *** |
0.5 | 0.9 | ||||||
12–10 Months | 0.00 | 0.15 | 12–10 Months | −0.65 | 1.46 | ||
10–8 Months | 0.00 | 0.01 | 10–8 Months | −1.42 | 0.84 | * | |
8–6 Months | 0.00 | 0.01 | 8–6 Months | −2.63 | 0.81 | *** | |
6–4 Months | 0.00 | 0.00 | 6–4 Months | 0.00 | 0.67 | ||
4–2 Months | −0.50 | 0.18 | ** | 4–2 Months | 0.13 | 0.65 | |
2–0 Months | −7.03 | 0.37 | *** | 2–0 Months | −4.05 | 0.65 | *** |
P<0.05,
P<0.01,
P<0.001
Months prior to buprenorphine induction